Serina Therapeutics, Inc. Net Fee Amt
Serina Therapeutics, Inc. (SER) had Net Fee Amt of $4.54 thousand as of 2026-08-24, per its S-1 filed 2026-08-24.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-24
- 2026-08-24: Net Fee Amt $4.54K.
- 2026-08-13: Net Fee Amt $626.97.
- 2026-05-22: Net Fee Amt $3.57K.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-24 | $4.54K S-1 · filed 2026-08-24 |
| 2026-08-13 | $626.97 S-8 · filed 2026-08-13 |
| 2026-05-22 | $3.57K S-3 · filed 2026-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |